Covid: Remdesivir ‘has little or no impact’ on survival, says WHO
For their clinical solidarity study, the WHO tested the effects of four possible treatments – remdesivir, an Ebola drug, was one, but they also looked at the malaria drug hydroxychloroquine, interferon, and the HIV drug combination of lopinavir and ritonavir.
Comments are closed.